Company Filing History:
Years Active: 2017-2020
Title: Thomas Dino Rockel: Innovator in Oligonucleotide Compounds
Introduction
Thomas Dino Rockel is a notable inventor based in Dusseldorf, Germany. He has made significant contributions to the field of oligonucleotide compounds, holding a total of five patents. His work focuses on developing innovative solutions that enhance gene expression inhibition.
Latest Patents
Rockel's latest patents include advancements in multimeric oligonucleotide compounds. These compounds consist of two or more target-specific oligonucleotides, such as antisense oligonucleotides (ASOs), which are resistant to cleavage and linked by a cleavable linker. This innovative approach allows for the concomitant inhibition of multiple genes' expression levels, while also exhibiting favorable pharmacokinetic and pharmacodynamic properties. The methods of making and utilizing these compounds are also detailed in his patents.
Career Highlights
Throughout his career, Rockel has worked with prominent companies in the biotechnology sector, including Translate Bio, Inc. and Rana Therapeutics, Inc. His experience in these organizations has contributed to his expertise in the development of oligonucleotide therapies.
Collaborations
Rockel has collaborated with notable professionals in his field, including Eugen Uhlmann and Markus Weber. These partnerships have furthered his research and innovation in oligonucleotide compounds.
Conclusion
Thomas Dino Rockel is a distinguished inventor whose work in oligonucleotide compounds has the potential to impact gene therapy significantly. His innovative patents and collaborations highlight his commitment to advancing biotechnology.